Binding and killing of bacteria by bismuth subsalicylate.

Sharon Woods Technical Center, Procter and Gamble Company, Cincinnati, Ohio 45241.
Antimicrobial Agents and Chemotherapy (Impact Factor: 4.57). 01/1990; 33(12):2075-82. DOI: 10.1128/AAC.33.12.2075
Source: PubMed

ABSTRACT Bismuth subsalicylate (BSS) is a compound without significant aqueous solubility that is widely used for the treatment of gastrointestinal disorders. BSS was able to bind bacteria of diverse species, and these bound bacteria were subsequently killed. A 4-log10 reduction of viable bacteria occurred within 4 h after a 10 mM aqueous suspension of BSS was inoculated with 2 x 10(6) Escherichia coli cells per ml. Binding and killing were dependent on the levels of inoculated bacteria, and significant binding but little killing of the exposed bacteria occurred at an inoculum level of 2 x 10(9) E. coli per ml. Intracellular ATP decreased rapidly after exposure of E. coli to 10 mM BSS and, after 30 min, was only 1% of the original level. Extracellular ATP increased after exposure to BSS, but the accumulation of extracellular ATP was not sufficient to account for the loss of intracellular ATP. The killing of bacteria exposed to BSS may have been due to cessation of ATP synthesis or a loss of membrane integrity. Bactericidal activity of BSS was also investigated in a simulated gastric juice at pH 3. Killing of E. coli at this pH was much more rapid than at pH 7 and was apparently due to salicylate released by the conversion of BSS to bismuth oxychloride. It is proposed that the binding and killing observed for BSS contribute to the efficacy of this compound against gastrointestinal infections such as traveler's diarrhea.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The title compound, C(10)H(8)O(3), has been synthesized as part of our investigations into the generation of new anti-bacterial agents and serves as a building block for the synthesis of compound libraries. The compound crystallizes with two independent mol-ecules in the asymmetric unit. The transoid propynyl ester groups are coplanar with the 2-hydroxy-benzoate group with maximum deviations of -0.3507 (3) and 0.1591 (3) Å for the terminal carbons, with intra-molecular O-H⋯O hydrogen bonding providing rigidity to the structure and ensuring that the reactivity of the alkyne is not compromised by steric factors. The propynyl group forms inter-molecular C-H⋯O inter-actions with the phenolic O atom. Supra-molecular chains along the b axis are found for both mol-ecules with links by weak O-H⋯O inter-molecular inter-actions in the first independent mol-ecule and C-H⋯O inter-actions in the second.
    Acta Crystallographica Section E Structure Reports Online 01/2009; 66(Pt 1):o226-7. · 0.35 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Adherence ofEscherichia coli isfacilitated byfimbriae andseveral outermembraneproteins (OMPs). Hypertonic conditions, salicylate, andMarmutations areknowntoreduce OmpFexpression. We speculated thatOMPsinvolved inexport orassembly offimbrial subunits might besimilarly affected. Toexplore this hypothesis, E.coli expressing P,type1,S,colonization factor antigen I(CFA/I), orCFA/II fimbriae wasgrown inthepresence ofsalicylate, bismuth salts, NaCl, andnonfermented sugars. Tetracycline-resistant clones were derived fromseveral P-fimbriated strains. Thebacteria weretested fortheability toagglutinate erythrocytes, yeast cells, anda-D-Gal(-4)-,I-D-Gal-bonded latex (Gal-Gal) beadsandwereexamined forfimbriae byelectron microscopy. Hyperosmolar conditions decreased fimbrial expression forallstrains. Expression ofPfimbriae bypyelonephritic strains, allofwhichwereOmpF+,wasreversibly repressed bysalicylate andbismuth salts. CFAstrains weresimilarly affected. Tetracycline-resistant P-fimbriated strains wereOmpFdeficient, were unable toagglutinate erythrocytes andGal-Gal beads, andlacked fimbriae asobserved byelectron microscopy. Strains withplasmid-encoded P-fimbrial genesdidnotdemonstrate OmpFonpolyacrylamide gelelectro- phoresis profiles andwerenotaffected bysalicylate. Thetype1-fimbriated phenotype wasnotaffected by salicylate orbismuth unless thestrains alsoexpressed Pfimbriae. S-fimbriated strains werenotaffected. The mechanism bywhichsalicylates, bismuth salts, andtetracycline resistance inhibit ormodulate theexpression ofPfimbriae maybemediated through OmpFandother OMPs.
  • Source
    BMJ Clinical Research 01/1996; 311(7021):1660-1. · 14.09 Impact Factor


Available from